Analysis

Medicenna Therapeutics Corp. (MDNA) Stock Analysis

Medicenna Therapeutics Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to MDNA.

websiteMDNA/analysis/MDNA

Medicenna Therapeutics Corp.

Medicenna Therapeutics Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to MDNA.

Stock profile

Ticker

MDNA

Asset type

Stock

Market cap

$20.9M

Sector

Health Technology

Industry

Biotechnology

Currency

CAD

Ticker listings

Medicenna Therapeutics Corp. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • MDNA primary listing
  • MDNAF

Latest Medicenna Therapeutics Corp. news

Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms

New U.S. patents extend protection for cellular immunotherapy applications, immune cell targeting constructs and bizaxofusp combination therapy with anti-VEGF agents for CNS tum...

Medicenna's MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026

NEO-CYT positions MDNA11 in a frontline neoadjuvant melanoma setting, where immunotherapy before ...

Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs

Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead

Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet

Base shelf prospectus is accessible on SEDAR+NOT FOR DISSEMINATION INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO and HOUSTON, May 22, 2026 (GLOBE ...

Medicenna Announces the Finalization of the Terms of its Public Offering of Securities

Base shelf prospectus is accessible, and prospectus supplement will be accessible within two busi...

Research sections

Valuation

Review valuation context for Medicenna Therapeutics Corp..

Future growth

Review future growth context for Medicenna Therapeutics Corp..

Past performance

Review past performance context for Medicenna Therapeutics Corp..

Financial health

Review financial health context for Medicenna Therapeutics Corp..

Dividend

Review dividend context for Medicenna Therapeutics Corp..

Management

Review management context for Medicenna Therapeutics Corp..

Ownership

Review ownership context for Medicenna Therapeutics Corp..

Other information

Review other information context for Medicenna Therapeutics Corp..

Community

Review community context for Medicenna Therapeutics Corp..